32
Views
35
CrossRef citations to date
0
Altmetric
Article

Sustained Platelet-Derived Growth Factor Receptor α Signaling in Osteoblasts Results in Craniosynostosis by Overactivating the Phospholipase C-γ Pathway

, , , , &
Pages 881-891 | Received 04 Jun 2008, Accepted 20 Nov 2008, Published online: 21 Mar 2023

REFERENCES

  • Akeno, N., J. Robins, M. Zhang, M. F. Czyzyk-Krzeska, and T. L. Clemens. 2002. Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha. Endocrinology 143:420–425.
  • Anderson, H. C. 1995. Molecular biology of matrix vesicles. Clin. Orthop. Relat. Res. 314:266–280.
  • Barnes, G. L., A. Javed, S. M. Waller, M. H. Kamal, K. E. Hebert, M. Q. Hassan, A. Bellahcene, A. J. Van Wijnen, M. F. Young, J. B. Lian, G. S. Stein, and L. C. Gerstenfeld. 2003. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res. 63:2631–2637.
  • Bazenet, C. E., J. A. Gelderloos, and A. Kazlauskas. 1996. Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation. Mol. Cell. Biol. 16:6926–6936.
  • Bellows, C. G., J. N. Heersche, and J. E. Aubin. 1992. Inorganic phosphate added exogenously or released from beta-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone Miner. 17:15–29.
  • Betsholtz, C., L. Karlsson, and P. Lindahl. 2001. Developmental roles of platelet-derived growth factors. Bioessays 23:494–507.
  • Bradley, J. P., J. P. Levine, C. Blewett, T. Krummel, J. G. McCarthy, and M. T. Longaker. 1996. Studies in cranial suture biology: in vitro cranial suture fusion. Cleft Palate Craniofac. J. 33:150–156.
  • Carinci, P., E. Becchetti, and M. Bodo. 2000. Role of the extracellular matrix and growth factors in skull morphogenesis and in the pathogenesis of craniosynostosis. Int. J. Dev. Biol. 44:715–723.
  • Chai, Y., X. Jiang, Y. Ito, P. Bringas, Jr., J. Han, D. H. Rowitch, P. Soriano, A. P. McMahon, and H. M. Sucov. 2000. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 127:1671–1679.
  • Chaudhary, L. R., A. M. Hofmeister, and K. A. Hruska. 2004. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 34:402–411.
  • Cohen, M. M., Jr. 1988. Craniosynostosis update 1987. Am. J. Med. Genet. Suppl. 4:99–148.
  • Cohen, M. M., Jr. 1995. Craniosynostosis: phenotypic/molecular correlations. Am. J. Med. Genet. 56:334–339.
  • Danielian, P. S., D. Muccino, D. H. Rowitch, S. K. Michael, and A. P. McMahon. 1998. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8:1323–1326.
  • Eriksson, A., E. Nanberg, L. Ronnstrand, U. Engstrom, U. Hellman, E. Rupp, G. Carpenter, C. H. Heldin, and L. Claesson-Welsh. 1995. Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors. J. Biol. Chem. 270:7773–7781.
  • Garimella, R., X. Bi, N. Camacho, J. B. Sipe, and H. C. Anderson. 2004. Primary culture of rat growth plate chondrocytes: an in vitro model of growth plate histotype, matrix vesicle biogenesis and mineralization. Bone 34:961–970.
  • Ge, C., G. Xiao, D. Jiang, and R. T. Franceschi. 2007. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell Biol. 176:709–718.
  • Gutierrez, S., A. Javed, D. K. Tennant, M. van Rees, M. Montecino, G. S. Stein, J. L. Stein, and J. B. Lian. 2002. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277:1316–1323.
  • Hall, B. K. 1999. Bone. Telford Press, Caldwell, NJ.
  • Hammacher, A., U. Hellman, A. Johnsson, A. Ostman, K. Gunnarsson, B. Westermark, A. Wasteson, and C. H. Heldin. 1988. A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J. Biol. Chem. 263:16493–16498.
  • Harada, H., S. Tagashira, M. Fujiwara, S. Ogawa, T. Katsumata, A. Yamaguchi, T. Komori, and M. Nakatsuka. 1999. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J. Biol. Chem. 274:6972–6978.
  • Hart, C. E., M. Bailey, D. A. Curtis, S. Osborn, E. Raines, R. Ross, and J. W. Forstrom. 1990. Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry 29:166–172.
  • Heinrich, M. C., C. L. Corless, A. Duensing, L. McGreevey, C. J. Chen, N. Joseph, S. Singer, D. J. Griffith, A. Haley, A. Town, G. D. Demetri, C. D. Fletcher, and J. A. Fletcher. 2003. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708–710.
  • Hirota, S., A. Ohashi, T. Nishida, K. Isozaki, K. Kinoshita, Y. Shinomura, and Y. Kitamura. 2003. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology 125:660–667.
  • Horner, A., S. Bord, P. Kemp, D. Grainger, and J. E. Compston. 1996. Distribution of platelet-derived growth factor (PDGF) A chain mRNA, protein, and PDGF-alpha receptor in rapidly forming human bone. Bone 19:353–362.
  • Jager, R., J. Maurer, A. Jacob, and H. Schorle. 2004. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation. Genesis 38:145–150.
  • Jiang, X., S. Iseki, R. E. Maxson, H. M. Sucov, and G. M. Morriss-Kay. 2002. Tissue origins and interactions in the mammalian skull vault. Dev. Biol. 241:106–116.
  • Klinghoffer, R. A., B. Duckworth, M. Valius, L. Cantley, and A. Kazlauskas. 1996. Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity. Mol. Cell. Biol. 16:5905–5914.
  • Kono, S. J., Y. Oshima, K. Hoshi, L. F. Bonewald, H. Oda, K. Nakamura, H. Kawaguchi, and S. Tanaka. 2007. Erk pathways negatively regulate matrix mineralization. Bone 40:68–74.
  • Kratchmarova, I., B. Blagoev, M. Haack-Sorensen, M. Kassem, and M. Mann. 2005. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308:1472–1477.
  • Lasota, J., A. Dansonka-Mieszkowska, L. H. Sobin, and M. Miettinen. 2004. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab. Investig. 84:874–883.
  • Liu, F., L. Malaval, and J. E. Aubin. 2003. Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J. Cell Sci. 116:1787–1796.
  • Lynch, S. E., S. B. Trippel, R. D. Finkelman, R. A. Hernandez, C. P. Kiritsy, and H. N. Antoniades. 1994. The combination of platelet-derived growth factor-BB and insulin-like growth factor-I stimulates bone repair in adult Yucatan miniature pigs. Wound Repair Regen. 2:182–190.
  • Matei, D., R. E. Emerson, Y. C. Lai, L. A. Baldridge, J. Rao, C. Yiannoutsos, and D. D. Donner. 2006. Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer. Oncogene 25:2060–2069.
  • Medeiros, F., C. L. Corless, A. Duensing, J. L. Hornick, A. M. Oliveira, M. C. Heinrich, J. A. Fletcher, and C. D. Fletcher. 2004. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am. J. Surg. Pathol. 28:889–894.
  • Mitlak, B. H., R. D. Finkelman, E. L. Hill, J. Li, B. Martin, T. Smith, M. D'Andrea, H. N. Antoniades, and S. E. Lynch. 1996. The effect of systemically administered PDGF-BB on the rodent skeleton. J. Bone Miner. Res. 11:238–247.
  • Morrison-Graham, K., G. C. Schatteman, T. Bork, D. F. Bowen-Pope, and J. A. Weston. 1992. A PDGF receptor mutation in the mouse (Patch) perturbs the development of a non-neuronal subset of neural crest-derived cells. Development 115:133–142.
  • Moss, M. L. 1958. Fusion of the frontal suture in the rat. Am. J. Anat. 102:141–165.
  • Newberry, E. P., T. Latifi, and D. A. Towler. 1998. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 37:16360–16368.
  • Orr-Urtreger, A., M. T. Bedford, M. S. Do, L. Eisenbach, and P. Lonai. 1992. Developmental expression of the alpha receptor for platelet-derived growth factor, which is deleted in the embryonic lethal Patch mutation. Development 115:289–303.
  • Paredes, R., G. Arriagada, F. Cruzat, A. Villagra, J. Olate, K. Zaidi, A. van Wijnen, J. B. Lian, G. S. Stein, J. L. Stein, and M. Montecino. 2004. Bone-specific transcription factor Runx2 interacts with the 1α,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol. Cell. Biol. 24:8847–8861.
  • Payne, J., F. Shibasaki, and M. Mercola. 1997. Spina bifida occulta in homozygous Patch mouse embryos. Dev. Dyn. 209:105–116.
  • Peitz, M., R. Jager, C. Patsch, A. Jager, A. Egert, H. Schorle, and F. Edenhofer. 2007. Enhanced purification of cell-permeant Cre and germline transmission after transduction into mouse embryonic stem cells. Genesis 45:508–517.
  • Pfisterer, P., J. Ehlermann, M. Hegen, and H. Schorle. 2002. A subtractive gene expression screen suggests a role of transcription factor AP-2 alpha in control of proliferation and differentiation. J. Biol. Chem. 277:6637–6644.
  • Rice, D. P., T. Aberg, Y. Chan, Z. Tang, P. J. Kettunen, L. Pakarinen, R. E. Maxson, and I. Thesleff. 2000. Integration of FGF and TWIST in calvarial bone and suture development. Development 127:1845–1855.
  • Roca, H., M. Phimphilai, R. Gopalakrishnan, G. Xiao, and R. T. Franceschi. 2005. Cooperative interactions between RUNX2 and homeodomain protein-binding sites are critical for the osteoblast-specific expression of the bone sialoprotein gene. J. Biol. Chem. 280:30845–30855.
  • Rydziel, S., C. Ladd, T. L. McCarthy, M. Centrella, and E. Canalis. 1992. Determination and expression of platelet-derived growth factor-AA in bone cell cultures. Endocrinology 130:1916–1922.
  • Schatteman, G. C., K. Morrison-Graham, A. van Koppen, J. A. Weston, and D. F. Bowen-Pope. 1992. Regulation and role of PDGF receptor alpha-subunit expression during embryogenesis. Development 115:123–131.
  • Shirakabe, K., K. Terasawa, K. Miyama, H. Shibuya, and E. Nishida. 2001. Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 6:851–856.
  • Sierra, O. L., S. L. Cheng, A. P. Loewy, N. Charlton-Kachigian, and D. A. Towler. 2004. MINT, the Msx2 interacting nuclear matrix target, enhances Runx2-dependent activation of the osteocalcin fibroblast growth factor response element. J. Biol. Chem. 279:32913–32923.
  • Smith, E. A., M. F. Seldin, L. Martinez, M. L. Watson, G. G. Choudhury, P. A. Lalley, J. Pierce, S. Aaronson, J. Barker, S. L. Naylor, et al. 1991. Mouse platelet-derived growth factor receptor alpha gene is deleted in W19H and patch mutations on chromosome 5. Proc. Natl. Acad. Sci. USA 88:4811–4815.
  • Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70–71.
  • Soriano, P. 1997. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 124:2691–2700.
  • Stephenson, D. A., M. Mercola, E. Anderson, C. Y. Wang, C. D. Stiles, D. F. Bowen-Pope, and V. M. Chapman. 1991. Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation. Proc. Natl. Acad. Sci. USA 88:6–10.
  • Sun, T., D. Jayatilake, G. B. Afink, P. Ataliotis, M. Nister, W. D. Richardson, and H. K. Smith. 2000. A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth. Development 127:4519–4529.
  • Tallquist, M. D., and P. Soriano. 2003. Cell autonomous requirement for PDGFRalpha in populations of cranial and cardiac neural crest cells. Development 130:507–518.
  • Valius, M., C. Bazenet, and A. Kazlauskas. 1993. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor β subunit and are required for binding of phospholipase Cγ and a 64-kilodalton protein, respectively. Mol. Cell. Biol. 13:133–143.
  • Wardelmann, E., A. Hrychyk, S. Merkelbach-Bruse, K. Pauls, J. Goldstein, P. Hohenberger, I. Losen, C. Manegold, R. Buttner, and T. Pietsch. 2004. Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. J. Mol. Diagn. 6:197–204.
  • Warren, S. M., L. J. Brunet, R. M. Harland, A. N. Economides, and M. T. Longaker. 2003. The BMP antagonist noggin regulates cranial suture fusion. Nature 422:625–629.
  • Warren, S. M., J. A. Greenwald, J. A. Spector, P. Bouletreau, B. J. Mehrara, and M. T. Longaker. 2001. New developments in cranial suture research. Plast. Reconstr. Surg. 107:523–540.
  • Werling, U., and H. Schorle. 2002. Transcription factor gene AP-2γ essential for early murine development. Mol. Cell. Biol. 22:3149–3156.
  • Wilkie, A. O., and G. M. Morriss-Kay. 2001. Genetics of craniofacial development and malformation. Nat. Rev. Genet. 2:458–468.
  • Xie, J., M. Aszterbaum, X. Zhang, J. M. Bonifas, C. Zachary, E. Epstein, and F. McCormick. 2001. A role of PDGFRalpha in basal cell carcinoma proliferation. Proc. Natl. Acad. Sci. USA 98:9255–9259.
  • Yu, J., T. F. Deuel, and H. R. Kim. 2000. Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta-induced phenotypic transformation. J. Biol. Chem. 275:19076–19082.
  • Yu, X., S. C. Hsieh, W. Bao, and D. T. Graves. 1997. Temporal expression of PDGF receptors and PDGF regulatory effects on osteoblastic cells in mineralizing cultures. Am. J. Physiol. 272:C1709–C1716.
  • Zaidi, S. K., A. Javed, J. Y. Choi, A. J. van Wijnen, J. L. Stein, J. B. Lian, and G. S. Stein. 2001. A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci. 114:3093–3102.
  • Zhang, L., E. Leeman, D. C. Carnes, and D. T. Graves. 1991. Human osteoblasts synthesize and respond to platelet-derived growth factor. Am. J. Physiol. 261:C348–C354.
  • Zhen, X., J. P. Bonjour, and J. Caverzasio. 1997. Platelet-derived growth factor stimulates sodium-dependent Pi transport in osteoblastic cells via phospholipase Cgamma and phosphatidylinositol 3′-kinase. J. Bone Miner. Res. 12:36–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.